Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • lung cancer

    Tag: lung cancer

    You Searched For "lung cancer"
    FDA grants priority review to Roches Tecentriq monotherapy as first-line treatment in certain lung cancer cases

    FDA grants priority review to Roche's Tecentriq monotherapy as first-line treatment in certain lung cancer cases

    Medical Dialogues Bureau20 Feb 2020 2:20 PM IST
    Basel: Roche announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) and...
    Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial

    Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial

    Medical Dialogues Bureau3 Nov 2019 9:00 AM IST
    Bristol-Myers Squibb said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to...
    Mirati Therapeutics oral drug MRTX849 shrinks tumours in early-stage trial

    Mirati Therapeutics oral drug MRTX849 shrinks tumours in early-stage trial

    Medical Dialogues Bureau2 Nov 2019 9:00 AM IST
    Out of 17 patients enrolled in the Phase 1 trial of Mirati Therapeutics' oral drug MRTX849, 12 have been evaluated, including six with lung cancer and...
    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Farhat Nasim1 Sept 2019 2:33 PM IST
    New Delhi: In a major relief to Natco, the Delhi High Court has lifted a ban on Natco Pharma from manufacturing fresh stock of on-small cell lung...
    Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month

    Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month

    Medical Dialogues Bureau17 Aug 2019 9:15 AM IST
    Rozlytrek was approved by the U.S. Food and Drug Administration on Thursday to treat certain types of solid tumours, which show rare genetic anomalies...
    Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer

    Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer

    Medical Dialogues Bureau12 Jun 2019 9:50 AM IST
    The approval is based on results from a late-stage trial, where Keytruda showed a significant improvement in overall survival in cancer patients,...
    Sun Pharma launches cancer drug INFUGEM in US market

    Sun Pharma launches cancer drug INFUGEM in US market

    Farhat Nasim9 April 2019 10:05 AM IST
    Sun Pharma said INFUGEM uses its proprietary technology which allows cytotoxic oncology products to be premixed in a sterile environment and supplied...
    Pfizer gets EU nod to VIZIMPRO for treating lung cancer

    Pfizer gets EU nod to VIZIMPRO for treating lung cancer

    Farhat Nasim6 April 2019 9:40 AM IST
    New Delhi: Pfizer Inc. recently announced that the European Commission has approved VIZIMPRO (dacomitinib), a tyrosine kinase inhibitor (TKI), as...
    J&J passes asbestos test, allowed to make baby powder in India

    J&J passes asbestos test, allowed to make baby powder in India

    Farhat Nasim1 March 2019 2:28 PM IST
    NEW DELHI: In a major relief to Johnson & Johnson(J&J), no asbestos was found in the baby powder manufactured in Baddi and Mulund plants. The...
    Another trouble for J&J: CDSCO seize samples of baby products for testing

    Another trouble for J&J: CDSCO seize samples of baby products for testing

    Farhat Nasim22 Dec 2018 12:14 PM IST
    The action by CDSCO has come at a time when the company is already embroiled in a controversy over its faulty hip implants. New Delhi: Following...
    Asbestos scare: CDSCO draws samples of J&J baby powder from HP plant

    Asbestos scare: CDSCO draws samples of J&J baby powder from HP plant

    Medical Dialogues Bureau20 Dec 2018 5:12 PM IST
    The CDSCO, under the Union Health Ministry, said over the next four to five days, drug inspectors will search manufacturing plants and wholesalers of...
    Roche drug cocktail doubles chance of holding lung cancer at bay

    Roche drug cocktail doubles chance of holding lung cancer at bay

    Ruby Khatun Khatun9 Dec 2017 9:45 AM IST
    ZURICH: Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok